Baillie Gifford & Co 13F, Q3 2023
Baillie Gifford · quarter ending 30 September 2023 · filed 13 November 2023 · SEC CIK 1088875
Common stock only: shares the fund reported owning at the quarter end, valued as filed.
Largest positions, Q3 2023
The 25 largest of 289 positions. Weights are against the whole filed book. Changes are in shares held, against the Q2 2023 filing.
| Company | Ticker | Value | % of book | vs Q2 2023 |
|---|---|---|---|---|
| MercadoLibre | MELI | $7.65B | 7.0% | -6% shares |
| NVIDIA | NVDA | $5.99B | 5.5% | -12% shares |
| Tesla Inc | TSLA | $5.58B | 5.1% | -4% shares |
| Amazon.Com | AMZN | $5.25B | 4.8% | unchanged |
| Moderna Inc | MRNA | $4.72B | 4.3% | unchanged |
| Spotify Technology SA | $3.84B | 3.5% | unchanged | |
| PDD Holdings Inc | PDD | $3.50B | 3.2% | +14% shares |
| The Trade Desk | TTD | $3.49B | 3.2% | unchanged |
| Shopify 'A' | SHOP | $3.42B | 3.1% | -4% shares |
| Ferrari NV | $2.13B | 1.9% | unchanged | |
| Coupang | CPNG | $2.03B | 1.9% | +8% shares |
| Netflix Inc | NFLX | $2.01B | 1.8% | -6% shares |
| Cloudflare Inc | NET | $1.96B | 1.8% | unchanged |
| Microsoft | MSFT | $1.70B | 1.6% | -3% shares |
| Dexcom Inc | DXCM | $1.56B | 1.4% | unchanged |
| Workday Inc | WDAY | $1.52B | 1.4% | unchanged |
| Atlassian Corp Plc | TEAM | $1.47B | 1.3% | unchanged |
| Alnylam Pharmaceuticals | ALNY | $1.45B | 1.3% | -3% shares |
| Illumina | ILMN | $1.44B | 1.3% | -25% shares |
| Elevance Health Inc | ELV | $1.33B | 1.2% | -2% shares |
| Meta Platforms Inc | META | $1.28B | 1.2% | +12% shares |
| Moody's Corp | MCO | $1.20B | 1.1% | -4% shares |
| Intuitive Surgical | ISRG | $1.20B | 1.1% | unchanged |
| Sea Ltd ADR | SE | $1.15B | 1.1% | +20% shares |
| Martin Marietta Materials | MLM | $1.13B | 1.0% | -2% shares |
What changed since Q2 2023
Against the Q2 2023 filing, Baillie Gifford & Co opened 10 new positions, added to 45, trimmed 119, left 115 unchanged and exited 17. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.
New positions
and 2 more
Exited
- Howard Hugheswas $205.60M
- FUTUwas $44.26M
- Chinook Therapeuticswas $17.82M
- FRwas $11.97M
- Cooper Cos Inc/Thewas $10.62M
- XPwas $9.57M
- Tabula Rasa HealthCare Incwas $6.86M
- Spire Global Incwas $446.0K
and 9 more
Other quarters
Source: SEC Form 13F-HR, accession 0001088875-23-000112, filed by BAILLIE GIFFORD & CO. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.